microbiological characterization

PreclinicalBiologic

microbiological characterization is one of 10 biologic programs targeting Ventilator-Associated Pneumonia. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Ventilator-Associated PneumoniaActive, not recruiting

Ventilator-Associated PneumoniaPreclinical

Active, not recruiting

Competition

Competitive Landscape

14 competitors in Ventilator-Associated Pneumonia

#DrugCompanyPhaseTrials

Doribax

Shionogi

Approved

3 2

Merrem

BB. Braun Medical Inc.

Approved

2 3

Amikin

IInsmed Incorporated

Approved

1 4

Vancocin

HHikma Pharmaceuticals LLC

Approved

1 5

Bactrim

UUniversity of California, San Francisco

Phase 3

1 6

Peridex

DDexcel Pharma Technologies Ltd.

Preclinical

1 7

Antibiotic

Pfizer

Preclinical

1 8

Bacteriophage

AAdaptive Phage Therapeutics, Inc.

Preclinical

1 9

microbiological characterization

CCentre Hospitalier Universitaire Dijon

Preclinical

1 10

Beta Lactam Antibiotics

OOregon Health and Science University

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Ventilator-Associated Pneumonia1 trial

Structural and Microbiological Characterization of Endotracheal Tube Biofilm in Patients at Increased Risk for the Development of Ventilator-associated Pneumonia in the Intensive Care Unit

Completed·—··NCT04926493·61 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for microbiological characterization. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — microbiological characterization compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for microbiological characterization. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Centre Hospitalier Universitaire Dijon company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Biologic[2]
Highest Phase: Preclinical[1]
Company: CCentre Hospitalier Universitaire Dijon

microbiological characterization

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Ventilator-Associated Pneumonia1 trial

References

Drug Info

Quick Facts

Related News